Walking Program for Parkinson's Disease
(ActivatePD Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does require that there are no changes in Parkinson medication that affect Levodopa levels during the study period.
What data supports the effectiveness of the treatment Independent Walking Program using Walking Poles for Parkinson's Disease?
Is the Walking Program for Parkinson's Disease safe?
How does the Walking Program for Parkinson's Disease differ from other treatments?
The Walking Program for Parkinson's Disease, which includes an Independent Walking Program using Walking Poles, is unique because it incorporates Nordic Walking, a form of exercise that uses poles to engage the upper body, improving gait quality and balance more effectively than standard rehabilitation. This approach is cost-effective and enhances physical mobility and quality of life in Parkinson's patients.246910
What is the purpose of this trial?
* Study Purpose: The purpose of the study is to compare changes in activity levels and walking in people with Parkinson disease after an 8-week independent walking program with or without using walking poles.* Major parts of the Study:Before the walking program: You will wear an activity sensor on your upper leg for one week to track activity levels. Measurements will be taken of you while you are walking. If you are placed in the walking pole group, you will be trained on how to use walking poles.Independent walking program: You will be asked to walk at least 3 times each week for 8 weeks and keep a log of your walking. If you are in the walking pole group, you will walk with the poles.After the walking program: Your walking measurements will be collected as before the walking program. You will wear an activity sensor for one week.
Research Team
Tiffany Salido, DPT, PhD
Principal Investigator
Pacific Northwest University of Health Sciences
Eligibility Criteria
This trial is for individuals with Parkinson's Disease who are able to walk independently. Participants will be involved in an 8-week walking program and must commit to walking at least three times a week. They should also be willing to wear an activity sensor and keep a log of their walking.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments and are assigned to study groups
Independent Walking Program
Participants engage in an 8-week walking program with or without walking poles
Post-Intervention Assessment
Participants' walking measurements and activity levels are reassessed
Follow-up
Participants are contacted to complete questionnaires and report on walking activities
Treatment Details
Interventions
- Independent Walking Program using Walking Poles
- Independent Walking Program without Walking Poles
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pacific Northwest University of Health Sciences
Lead Sponsor